Clinical Trial Update: PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial examining the PED/PEA-15 protein in Polycystic Ovary Syndrome, focusing on insulin sensitivity, using me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Oral contraceptives (combined oral contraceptives)
• PED/PEA-15 protein (PED/PEA-15 protein)
• metformin (metformin)

Snippet

Sponsor: Federico II University | Conditions: Polycystic Ovarian Syndrome, Insulin Sensitivity | Phase 3 | Status: COMPLETED